Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes

Overview of attention for article published in Investigational New Drugs, May 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 50 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Ganetespib-containing particle, pharmaceutical composition comprising the same, and their…

Grant US-11013720-B2

United States of America

Combination therapy of HSP90 inhibitors with platinum-containing agents

Grant US-10500193-B2

United States of America

Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitors

Grant US-9439899-B2

United States of America

Combination therapy of HSP90 inhibitors with BRAF inhibitors

Grant US-9402831-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 1 additional patents.